News | May 24, 2024
Taro shareholders approve merger with Sun Pharma
The combined entity will enable us to better serve the needs of patients, healthcare professionals and our customers around the world
The combined entity will enable us to better serve the needs of patients, healthcare professionals and our customers around the world
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Phase I data for tuvusertib, lead asset from the company’s unique portfolio of DDR inhibitors
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
For use with Hamamatsu Images acquired with the NanoZoomer S360MD slide scanner
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
Additional data from APPRAISE ATP trial reinforce modular therapy approach
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
_256_384.jpeg)
ASG Group of Eye Hospitals has 165+ branches in 85+ cities across India and abroad
Data support the potential of Dupixent as the first new treatment approach in more than a decade and first-ever targeted therapy for COPD
Subscribe To Our Newsletter & Stay Updated
